Evidence map›Paper›PMID 30610382›Full record

Observational studyClinical research in cardiology : official journal of the German Cardiac Society2019

Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation.

Ify R Mordi, Bernadet T Santema, Mariëlle Kloosterman, Anna-Maria Choy, Michiel Rienstra, Isabelle van Gelder, Stefan D Anker, John G Cleland, Kenneth Dickstein, Gerasimos Filippatos and 12 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Clinical research in cardiology : official journal of the German Cardiac Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Observational
  8. Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 9 countries.

Ify R MordiDivision of Molecular and Clinical Medicine, Medical Research Institute, Mailbox 2, Ninewells Hospital & Medical School, University of Dundee, Dundee, DD1 9SY, UK. i.mordi@dundee.ac.uk.ORCID http://orcid.org/0000-0002-2686-729X
Bernadet T SantemaDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Mariëlle KloostermanDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Anna-Maria ChoyDivision of Molecular and Clinical Medicine, Medical Research Institute, Mailbox 2, Ninewells Hospital & Medical School, University of Dundee, Dundee, DD1 9SY, UK.
Michiel RienstraDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Isabelle van GelderDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Stefan D AnkerDivision of Cardiology (CVK), and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
John G ClelandNational Heart and Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London, UK.
Kenneth DicksteinUniversity of Bergen, Bergen, Norway.
Gerasimos FilippatosNational and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Pim van der HarstDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-2713-686X
Hans L HillegeDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Marco MetraDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health, Institute of Cardiology, University of Brescia, Brescia, Italy.
Leong L NgDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.
Wouter OuwerkerkDepartment of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Piotr PonikowskiDepartment of Heart Diseases, Wroclaw Medical University, Wrocław, Poland.
Nilesh J SamaniDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.
Dirk J van VeldhuisenDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Aeilko H ZwindermanDepartment of Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Inserm CIC 1433, Amsterdam, The Netherlands.
Faiez ZannadInserm CIC-P 1433, Université de Lorraine, CHRU de Nancy, FCRIN INI-CRCT, Nancy, France.
Adriaan A VoorsDepartment of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Chim C LangDivision of Molecular and Clinical Medicine, Medical Research Institute, Mailbox 2, Ninewells Hospital & Medical School, University of Dundee, Dundee, DD1 9SY, UK.
University Medical Center Groningen · NLAmsterdam UMC Location University of Amsterdam · NLUniversity of Dundee · GBUniversity of Leicester · GBHarefield Hospital · GBInserm · FRNational and Kapodistrian University of Athens · GRNinewells Hospital · GBStavanger University Hospital · NOUniversitätsmedizin Göttingen · DEUniversity of Brescia · ITWroclaw Medical University · PL

Funding

Chief Scientist Office PCL 17/07Chief Scientist Office PCL/17/07Dutch Heart Foundation CVON 2014-11 RECONNECTFP7 FP7-242209-BIOSTAT-CHF
6 · The paper itself

Abstract

backgroundIn patients with heart failure with reduced ejection fraction (HFrEF) on sub-optimal doses of beta-blockers, it is conceivable that changes in heart rate following treatment intensification might be important regardless of underlying heart rhythm. We aimed to compare the prognostic significance of both achieved heart rate and change in heart rate following beta-blocker uptitration in patients with HFrEF either in sinus rhythm (SR) or atrial fibrillation (AF).

methodsWe performed a post hoc analysis of the BIOSTAT-CHF study. We evaluated 1548 patients with HFrEF (mean age 67 years, 35% AF). Median follow-up was 21 months. Patients were evaluated at baseline and at 9 months. The combined primary outcome was all-cause mortality and heart failure hospitalisation stratified by heart rhythm and heart rate at baseline.

resultsDespite similar changes in heart rate and beta-blocker dose, a decrease in heart rate at 9 months was associated with reduced incidence of the primary outcome in both SR and AF patients [HR per 10 bpm decrease-SR: 0.83 (0.75-0.91), p < 0.001; AF: 0.89 (0.81-0.98), p = 0.018], whereas the relationship was less strong for achieved heart rate in AF [HR per 10 bpm higher-SR: 1.26 (1.10-1.46), p = 0.001; AF: 1.08 (0.94-1.23), p = 0.18]. Achieved heart rate at 9 months was only prognostically significant in AF patients with high baseline heart rates (p for interaction 0.017 vs. low).

conclusionsFollowing beta-blocker uptitration, both achieved and change in heart rate were prognostically significant regardless of starting heart rate in SR, however, they were only significant in AF patients with high baseline heart rate.

Indexed as

Adrenergic beta-AntagonistsAgedAtrial FibrillationDose-Response Relationship, DrugFemaleFollow-Up StudiesHeart FailureHeart RateHumansMalePrognosisProspective StudiesStroke VolumeTreatment OutcomeAdrenergic beta-AntagonistsAtrial fibrillationBeta-blockersHeart failureHeart rate

Identifiers

PMID30610382
PMCPMC6584244
OpenAlexW2906959631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.